Researcher
Current- Designed, formulated, and developed drug product candidates for new therapeutics against CMV, Dengue, CoV-2, and HIV
- Executed plasmid and LNP purification processes through the utilization of Fast Protein Liquid Chromatography (FPLC) and Tangential Flow Filtration (TFF,) ensuring high-quality products and efficient downstream.
- Conducted R&D experiments using analytical chemistry (Patfix) to generate data for determining optimal methods for nucleic acid and LNP yield and purification, resulting in improved processes in GMP product production.
- Spearheaded initiatives in project planning to meet restrictive deadlines on the HIV GMP therapeutic
- Managed and executed the transition from small-scale to large-scale plasmid production with bioreactors and a focus on optimizing efficiency and yield while ensuring adherence to GMP standards
- Implemented and developed comprehensive SOPs for the creation of a new preclinical GMP facility, ensuring quality control (QC) and regulatory compliance (QMS), streamlined operations, and adherence to aseptic techniques